Abstract

Central aortic pressure waveforms can be calculated from the radial artery pressure waveform using a generalized transfer function to correct for pressure wave distortion in the upper limb. Although validated to standards conventionally applied, reservations are still expressed on use of this process, because of the relatively small number of patients from whom appropriate invasive data were obtained. The study described here supplemented such data with noninvasive data obtained from carotid and radial artery tonometry in 439 patients and normal subjects. The carotid-radial artery transfer function was similar to the aortic-radial when allowance was made for wave travel from aorta to carotid artery. The carotid-radial transfer function was identical in male and female individuals, was similar at different arterial pressures and in mature adults. Differences are relatively small, are seen at frequencies where central pressure wave components are small and are similar to those seen with vasodilator agents in invasive studies. Findings provide further support for use of a generalized transfer function to calculate aortic from upper limb pressure and conform with previously established views on vascular impedance.

Controversy on this subject has recently sharpened with debate on the utility of transfer functions to generate the central from the peripheral pressure waveform.1–4 The background validity to this approach was established almost 50 years ago with justification of the transfer function approach confirmed on a theoretical and mathematical basis.5–7 Initially highly controversial,8,9 this approach is now sanctioned through acceptance of vascular impedance as the expression of pulsatile pressure/flow relationship in arteries, and ascending aortic impedance as a description of left ventricular hydraulic (after)load.10–12

The initial work done to establish, test, and confirm utility of the transfer function process for generating the central aortic from the upper limb pressure waveform was undertaken some 30 years later13–15 and, after robust challenge,16–18 was confirmed and accepted by regulatory bodies including the US Food and Drug Administration (FDA).19–21 The transfer function used in this study, expressed in the frequency domain, represents the ratio of amplitudes in harmonic series between the carotid and radial artery (radial/carotid in this study). Very recent challenge is based on failure to gain precise aortic values when the peripheral waveform is calibrated by cuff sphygmomanometer1,4 and, when using conventional fluid-filled manometers of low frequency response,2 in association with catheterization-suite recording systems that have damping filters installed for the convenience of clinicians.1,2

The purpose of this article is to present some of the noninvasive validation findings for the methods used, much of which was collected more than 10 years ago. At the time, this was regarded as simply confirmatory of published work and so was published only in thesis or review format22,23 or in abstract form24,25 and in the standard text.12 It does comprise data collected from more than 400 patients and subjects and is therefore the largest published to date in a journal article. The original data are currently unavailable, as a consequence of the translocation of laboratories and the death of one of the principal collaborators, Dr. Ray Kelly.

Methods

The noninvasive studies of transfer functions followed introduction of the Millar tonometer into clinical practice in 1987, its validation against intra-arterial pressure,26 and its use to describe changes in the radial, carotid, and femoral arterial pressure waveforms with age.27

Subjects

Subjects were recumbent and measurements were started after at least 5 min rest. Carotid and radial artery pressure waveforms were recorded sequentially (or vice versa) using a validated Millar tonometer26 with applanation technique. There were 439 adult subjects (282 men and 157 women) attending a cardiovascular outpatient clinic. Pressure waveforms were recorded after brachial systolic and diastolic measurements with mercury cuff sphygmomanometer using the Korotkov sound technique and phase 5 for diastolic pressure. Details of age, blood pressure, heart rate, cardiovascular disease, and treatment are given in Tables 12 to 3. All subjects gave informed consent for the procedures.

Table 1

Descriptive statistics for variables in study cohort of 439 subjects

VariableMeanSDRange
Age (years)58.816.3417–90
Heart rate (beats/min)70.011.438–107
Systolic pressure (mm Hg)142.324.192–228
Diastolic pressure (mm Hg)81.811.940–120
VariableMeanSDRange
Age (years)58.816.3417–90
Heart rate (beats/min)70.011.438–107
Systolic pressure (mm Hg)142.324.192–228
Diastolic pressure (mm Hg)81.811.940–120
Table 1

Descriptive statistics for variables in study cohort of 439 subjects

VariableMeanSDRange
Age (years)58.816.3417–90
Heart rate (beats/min)70.011.438–107
Systolic pressure (mm Hg)142.324.192–228
Diastolic pressure (mm Hg)81.811.940–120
VariableMeanSDRange
Age (years)58.816.3417–90
Heart rate (beats/min)70.011.438–107
Systolic pressure (mm Hg)142.324.192–228
Diastolic pressure (mm Hg)81.811.940–120
Table 2

Prevalence of cardiovascular disease in the study population

ClassificationYesNo
Normal83356
Hypertension157282
Ischemic heart disease229210
Left ventricular failure50389
Aortic valvular disease10429
Abdominal aortic aneurysm8431
Peripheral vascular disease21418
Atrial fibrillation7432
Cerebrovascular accident2437
ClassificationYesNo
Normal83356
Hypertension157282
Ischemic heart disease229210
Left ventricular failure50389
Aortic valvular disease10429
Abdominal aortic aneurysm8431
Peripheral vascular disease21418
Atrial fibrillation7432
Cerebrovascular accident2437
Table 2

Prevalence of cardiovascular disease in the study population

ClassificationYesNo
Normal83356
Hypertension157282
Ischemic heart disease229210
Left ventricular failure50389
Aortic valvular disease10429
Abdominal aortic aneurysm8431
Peripheral vascular disease21418
Atrial fibrillation7432
Cerebrovascular accident2437
ClassificationYesNo
Normal83356
Hypertension157282
Ischemic heart disease229210
Left ventricular failure50389
Aortic valvular disease10429
Abdominal aortic aneurysm8431
Peripheral vascular disease21418
Atrial fibrillation7432
Cerebrovascular accident2437
Table 3

Prevalence of drug therapy in cohort of 439 subjects

DrugYesNo
Treatment300139
-Blockers144295
Loop diuretics54385
Thiazides71368
ACE inhibitors87352
Nitrates, short acting3436
Nitrates, long acting66373
Calcium antagonists128311
Digitalis47392
Quinidine5434
-Antagonists9430
Hydralazine2437
Aldomet2437
Type 1 antiarrhythmic agents22417
Amiodarone7432
DrugYesNo
Treatment300139
-Blockers144295
Loop diuretics54385
Thiazides71368
ACE inhibitors87352
Nitrates, short acting3436
Nitrates, long acting66373
Calcium antagonists128311
Digitalis47392
Quinidine5434
-Antagonists9430
Hydralazine2437
Aldomet2437
Type 1 antiarrhythmic agents22417
Amiodarone7432

ACE = angiotensin converting enzyme.

Table 3

Prevalence of drug therapy in cohort of 439 subjects

DrugYesNo
Treatment300139
-Blockers144295
Loop diuretics54385
Thiazides71368
ACE inhibitors87352
Nitrates, short acting3436
Nitrates, long acting66373
Calcium antagonists128311
Digitalis47392
Quinidine5434
-Antagonists9430
Hydralazine2437
Aldomet2437
Type 1 antiarrhythmic agents22417
Amiodarone7432
DrugYesNo
Treatment300139
-Blockers144295
Loop diuretics54385
Thiazides71368
ACE inhibitors87352
Nitrates, short acting3436
Nitrates, long acting66373
Calcium antagonists128311
Digitalis47392
Quinidine5434
-Antagonists9430
Hydralazine2437
Aldomet2437
Type 1 antiarrhythmic agents22417
Amiodarone7432

ACE = angiotensin converting enzyme.

Analysis

Analogue waveforms were digitized at 128 samples/sec and recorded over a period of 8 sec. Differentials were used to identify the foot of the waveforms, and the series of waves were overlaid and ensemble-averaged to obtain a single wave for the radial or the carotid site. The peak and nadir of the radial waveform were set to sphygmomanometric systolic and diastolic pressure, respectively, for calibration of the whole waveform based on the constant properties of upper limb arteries and the short distance between brachial and radial measurement sites. On the basis of near identity of mean and diastolic pressure in central and peripheral arteries, as they vary relatively little throughout the conduit arterial system,19,28 the carotid mean and diastolic pressure were set as identical to radial mean and diastolic pressures and the carotid systolic pressure obtained by extrapolation.28 Mean arterial pressure was measured as an average of pressure over the total recording time. There were minimal changes in heart rate or other variables during the recording session, so the radial and carotid waveforms were regarded as though recorded simultaneously. Fourier analysis was undertaken on the ensemble-averaged waveforms with calculation of modulus and phase up to 10 Hz.

For determination of transfer function from aorta to radial artery, corresponding harmonic components were related in modulus only. Data points were excluded if modulus calculated from these data exceeded 4.0, the denominator was small, and the calculated value was considered unreliable.29 There were fewer than 20 such data points in the whole series. Phase was not expressed, as digitization was not set to the electrocardiograph.

Statistical method

In the frequency domain, the moduli for each frequency were compared using unpaired two-tail t test, with P values <.05 taken as indicating significant difference.

Validation

We did have the opportunity to test the correspondence of calculated central aortic pressure with the pressure measured directly in the aorta. A data set of 61 simultaneously recorded ascending aortic and radial pressure waveforms obtained from 61 patients scheduled for surgery before (control) and during intravenous infusion of nitroglycerine were analyzed, as previously published.19,21 We also analyzed another data set of 12 simultaneously recorded ascending aortic and radial pressure waveforms obtained from 12 patients scheduled for percutaneous transluminal coronary angioplasty before (control) and after a bolus dose of midazolam 1.0 to 2.0 mg, as previously described.20

Results

Modulus of transfer function increased up to a peak value of 1.8 between 3 and 6 Hz before falling toward unity at higher frequencies. Data are shown as mean ± standard deviation (Fig. 1). Considerable scatter at high frequencies is attributable to low amplitude of pressure harmonics at these frequencies (Fig. 1). Deviation between radial and carotid pressure moduli was greatest between 3 and 6 Hz and was least at the highest and lowest frequencies.

(Top) Transfer function in the full group of 439 patients. Data expressed as mean ± SD. Because of the large number of subjects (n = 439), the SEM for all values was <0.1 unit. (Bottom) Values of harmonic components from the carotid and radial pressure waves of these subjects. (From Ref. 22).

For comparison against invasively determined radial-aortic transfer function, the average values of modulus from Fig. 1 were adjusted, using the transfer function for aortic-carotid pressure amplification. When this was done, the calculated aortic-radial transfer function (Fig. 2, top tracing) was virtually identical to the invasively determined data published by Karamanoglu et al14 and Chen et al16 and up to the frequency of 4 Hz reported by Hope et al.2

Transfer functions of pressure waves in the radial and carotid arteries from the noninvasive study (middle tracing),22 shown together with transfer function of pressure waves between the ascending aorta and carotid artery (bottom tracing), and the ascending aorta-radial artery transfer function calculated from the two sets of data (top tracing). The calculated aorta-radial artery transfer function is very similar to that published by Karamanoglu et al14 and by Chen et al.16 AA-CA = aortic artery-carotid artery; AA-RA = aortic artery-radial artery; CA-RA = carotid artery-radial artery.

For studying the effects of gender, data from all female subjects were compared against those of male subjects. There were no significant differences in age, pathology, or drug treatment between the two groups. Women, however, tended to have higher systolic and pulse pressure than men. For practical purposes there was no significant difference between male and female subjects (Fig. 3, top). This was a surprise because, with shorter stature and arm length, we expected that women might show some separation (peak amplification at higher frequency), but this was not apparent. However, there was a significant difference between amplitude of the first three harmonics of pressure in the carotid and radial waves (Fig. 3, bottom). This explained the difference in systolic and pulse pressure between the two groups and may have been due to differences in body height, as this influenced wave reflection from the lower body.

(Top) Carotid/radial pressure transfer function plotted for males (•) and females (□). (Bottom) Comparison of carotid harmonic components from fundamental frequency. (From Ref. 22).

For studying the effects of mean arterial pressure in the upper limb transfer function, we separated subjects into those with mean pressure ≥120 mm Hg and those with mean pressure ≤90 mm Hg as compared with the whole group. Again, and surprisingly, there was little difference in modulus of the transfer function in the upper limb (Fig. 4, top). There was, however, a considerable difference in amplitude of the carotid pressure harmonics of those with high and low pressure (Fig. 4, bottom); this is readily explained on the basis of increased aortic impedance, aortic stiffening, and early wave reflection from the lower body in persons with the higher mean pressure.

Top) Carotid/radial pressure transfer function plotted for whole study population (▴), mean pressure >120 mm Hg (•), and mean pressure <90 mm Hg (□). (Bottom) Comparison of carotid harmonic components from fundamental frequency. HCA-RA = harmonics of carotid artery-radial artery. (From Ref. 22).

For studying the effects of age, we separated the population into those individuals ≥65 years, those ≤35 years, and the whole population (Fig. 5). There was an obvious difference between the youngest and older subjects that was readily apparent only at values >3 Hz. As for gender and arterial pressure, there were large differences in amplitude of the carotid harmonics up to 3 Hz. There were no differences above 3 Hz in amplitude of carotid harmonics.

(Top) Carotid/radial pressure transfer function plotted for whole study population (▴), for age group >65 years (•), and for age group <35 years (□). (Bottom) Comparison of carotid harmonic components from fundamental frequency. HCA-RA = harmonics of carotid artery-radial artery. (From Ref. 22).

If a generalized transfer function is to be used in any individual under different conditions, it must be established through validation studies such that central aortic pressure calculations correspond within accepted limits to the pressure measured directly in the central aorta, irrespective of age, gender, blood pressure, heart rate, disease, and drug therapy—or that any nonconformity be specified. Such data have been published and accepted by the Food and Drug Administration (FDA).19,21 These data are given in Fig. 6 (left). As for the noninvasively determined radial-carotid transfer function, findings under control conditions were virtually identical to those previously published, although the interventions were associated with a definite but small difference in modulus of amplification. However, as with the noninvasive carotid data, such differences were only apparent at the higher frequencies where amplitude of the initial waveform harmonics were very low. These data are presented together with transfer function data determined by us from another study,20 where high fidelity manometry was used (Fig. 6, right). Again there is correspondence with the values up to 4.0 Hz with some divergence at higher frequencies at which harmonic moduli were small.

(Left) Analysis of a data set of 61 simultaneously recorded ascending aortic and radial pressure waveforms before (control) and during intravenous infusion of nitroglycerine (NTG). Transfer function amplitude at baseline (control) and during infusion of NTG is given on the left vertical axis. Energy or power content (in %) at each harmonic frequency up to 10 Hz is given on the right axis. There was a close correspondence of transfer function over the frequency range that contained most of the energy of the pressure waveforms (0 to 3.3 Hz); more than 98% of the energy was contained over this frequency range. Above the frequency range at which deviation of transfer function was considerable (3.3 to 10 Hz), amplitude of pressure components was very low, with less than 2.0% of total energy. (Data collected by A. Pauca and N. Kon and analyzed by A. Qasem and M. O’Rourke.) (Right) Analysis of a data set of 12 simultaneously recorded ascending aortic and radial pressure waveforms before (control) and after a bolus dose of midazolam 1.0 to 2.0 mg. There was little difference in transfer function up to 3.0 Hz. Amplitude of pressure harmonics was very low over 3.0 Hz, at which point the transfer function curves diverged. (Data collected by S. Soderstrom, J. Sellgren, J. Ponten, and G. Nyberg and analyzed by A. Qasem and M. O’Rourke.)

Discussion

The assumption of linearity in pressure/pressure and pressure/flow relationships underlies the use of all transfer functions, where their relationship is expressed in the frequency domain, as modulus and phase plotted against frequency. In expressing the relationship between mean pressure and mean flow as resistance, this assumption is likewise implied. Use of transfer functions was initially championed by the English physiologist Donald McDonald in the mid-1950s,6,7 and was based on the theoretic studies of the mathematician John Womersley,5 who examined the Navier-Stokes equations as these apply in the arterial tree. Womersley concluded that nonlinearities, although present, were sufficiently small in comparison with measuring errors to be neglected “to a first approximation.” While justifying McDonald’s early approach, the views gained further confirmation from the work of McDonald’s protégé, Michael Taylor, who popularized the concept of vascular impedance through detailed physiologic and theoretical studies.11,30,31 By 1980, opposition to this basic concept had evaporated. The field was advanced by Murgo et al29 when new accurate manometers and flow meters were introduced for clinical and experimental studies.32 Development of accurate tonometers for noninvasive measurement of the arterial pressure waveform26,33,34 opened another field for use of transfer functions to describe the relationship between upper limb (brachial or radial) and central (aortic or carotid) waveforms.

It had long been known that there are substantial differences in amplitude and contour between aortic and upper limb pressure waves; under conditions such as exercise, the difference in systolic pressure was as much as 80 mm Hg.12,35,36 Hence, use of transfer functions or other processes to correct for such distortion assumed an important priority in human physiologic and clinical research.13

Transfer functions for pressure waves in the upper limb were first used by O’Rourke37 to attempt separation of cardiac and vascular factors in the interpretation of brachial pressure values. The next report was by Lasance et al38 in the Netherlands, with the objective of gaining more accurate measurements of pressure in arteries in which it had most physiologic (and clinical) relevance. Neither of the papers studied the effect of interventions, though both showed similarities within a group of patients. To be really useful, a transfer function must be sufficiently stable during various interventions that central pressure can be determined accurately during the intervention. The important clue that transfer function might be stable came from the observation that nitroglycerine caused similar changes in central and brachial artery waveforms.39 This concept was solidified by the finding in a small group of patients studied at cardiac catheterization and the observation that the brachial/aortic and radial/aortic transfer functions were similar before and after use of nitroglycerine.14 The same study also examined published data collected during exercise and various physiologic maneuvers35,36 and confirmed (relative) stability of the central-upper limb pressure transfer function. Realistic modeling studies15 provided further support.

It is not possible, through studies at cardiac catheterization, to test all variables that may affect the transfer function for pressure in the upper limb. Individuals undergo this procedure only when there is suspicion of disease and so cannot be considered as normal. There are problems with using conventional fluid-filled catheter manometer systems in that these are difficult to purge of bubbles and frequency response is rarely adequate.1,3,7,12,19 There are problems also in use of catheter-tip manometers, as their substitution for routine catheters prolongs the procedure (especially when an intervention is undertaken) and as they are expensive and are recommended only for single use. These restrictions led to the study of carotid-radial transfer functions as a surrogate of ascending aortic-radial. Data support use of the generalized transfer functions as used by us and by others, and show that the same generalized transfer function can reasonably be used in male and female individuals, at different arterial pressures, and in mature adults (Figs. 34 to 5). Data presented in Fig. 6 show a close correspondence of transfer function over the frequency range that contained most of the energy of the pressure waveforms (0.0 to 3.3 Hz), with more than 98% of the energy contained over this frequency range. Above the frequency range at which deviation of transfer function was considerable, amplitude of pressure components was very low, with less than 2% of total energy.

Data on transfer functions under control conditions from all published studies are shown in Fig. 7. Aorta-radial transfer functions were found to be similar in eight of ten studies. The dissimilarity of the other two transfer functions can be explained; low peak amplitude in the study by O’Rourke37 is attributable to measurement of peripheral pressure in the mid-proximal brachial artery, and the high amplitude after the peak in the study by Hope et al2 is attributable to low natural frequency and damping of the fluid-filled manometer system used for recording. In the eight other studies, there is good correspondence over the frequency range required (0.0 to 10.0 Hz) to identify systolic shoulder and systolic augmentation.

Composite figure showing upper limb transfer function modulus from Lasance et al,38 Karamanoglu et al,14,15 Gallagher,22 Chen et al,16 Fetics et al,17 O’Rourke,37 Hope et al,2 and from data provided by Soderstrom et al20 and Pauca et al.19 Low peak amplitude in the study by O’Rourke37 is attributable to measurement of central pressure in the aortic arch and distal pressure in the mid-proximal brachial artery. High amplitude after the peak in the study by Hope et al2 is attributable to low natural frequency, and damping of the fluid-filled manometer system used to record aortic pressure.

Generation of aortic pressure from upper limb pressure waveforms is a desirable goal, even if there is scant information available regarding clinical implications. What data exist show that values of central pressure are related to outcomes and more precisely related to outcomes than peripheral pressure values (Table 440,,,44 and Table 545,,,,,51). On a theoretic basis, this is what one would predict, as blood pressure-related complications occur in central arteries, not the upper limb. In comparison, left ventricular pressure during systole is almost exactly the same as that in the aorta, not the brachial artery, and the coronary perfusion pressure head is represented by the aortic pressure maintained during diastole.12

Table 4

Relationship between outcomes and noninvasively measured aortic or central pulse pressure

Authors (Ref.)Study Finding
Waddell et al40Predictor of coronary atherosclerosis
Safar et al41All-cause and cardiovascular disease-related mortality
Boutouyrie et al42Carotid artery intima-media thickness*
Boutouyrie et al43Regression with therapy dependent on change in carotid pulse pressure*
Boutouyrie et al44Primary coronary events*
Authors (Ref.)Study Finding
Waddell et al40Predictor of coronary atherosclerosis
Safar et al41All-cause and cardiovascular disease-related mortality
Boutouyrie et al42Carotid artery intima-media thickness*
Boutouyrie et al43Regression with therapy dependent on change in carotid pulse pressure*
Boutouyrie et al44Primary coronary events*
*

Specifically noted, no relation to brachial blood pressure.

Table 4

Relationship between outcomes and noninvasively measured aortic or central pulse pressure

Authors (Ref.)Study Finding
Waddell et al40Predictor of coronary atherosclerosis
Safar et al41All-cause and cardiovascular disease-related mortality
Boutouyrie et al42Carotid artery intima-media thickness*
Boutouyrie et al43Regression with therapy dependent on change in carotid pulse pressure*
Boutouyrie et al44Primary coronary events*
Authors (Ref.)Study Finding
Waddell et al40Predictor of coronary atherosclerosis
Safar et al41All-cause and cardiovascular disease-related mortality
Boutouyrie et al42Carotid artery intima-media thickness*
Boutouyrie et al43Regression with therapy dependent on change in carotid pulse pressure*
Boutouyrie et al44Primary coronary events*
*

Specifically noted, no relation to brachial blood pressure.

Table 5

Relationship between outcomes and directly measured aortic pressure

Authors (Ref.)Study Finding
Pulse pressure
 Lu et al45Restenosis after coronary angioplasty, OR = 5.9 for pulse pressure >66 mm Hg
 Nishijima et al46Severity of coronary disease*
 Chemla et al47Relation to concentric left ventricular hypertrophy
 Philippe F et al48Extent of coronary disease*
 Nakayama et al49Restenosis after coronary angioplasty
Augmentation index
 Hayashi et al50Severity of coronary disease, OR = 16.2
 Ueda et al51Restenosis after coronary angioplasty
Authors (Ref.)Study Finding
Pulse pressure
 Lu et al45Restenosis after coronary angioplasty, OR = 5.9 for pulse pressure >66 mm Hg
 Nishijima et al46Severity of coronary disease*
 Chemla et al47Relation to concentric left ventricular hypertrophy
 Philippe F et al48Extent of coronary disease*
 Nakayama et al49Restenosis after coronary angioplasty
Augmentation index
 Hayashi et al50Severity of coronary disease, OR = 16.2
 Ueda et al51Restenosis after coronary angioplasty

OR = odds ratio.

Table 5

Relationship between outcomes and directly measured aortic pressure

Authors (Ref.)Study Finding
Pulse pressure
 Lu et al45Restenosis after coronary angioplasty, OR = 5.9 for pulse pressure >66 mm Hg
 Nishijima et al46Severity of coronary disease*
 Chemla et al47Relation to concentric left ventricular hypertrophy
 Philippe F et al48Extent of coronary disease*
 Nakayama et al49Restenosis after coronary angioplasty
Augmentation index
 Hayashi et al50Severity of coronary disease, OR = 16.2
 Ueda et al51Restenosis after coronary angioplasty
Authors (Ref.)Study Finding
Pulse pressure
 Lu et al45Restenosis after coronary angioplasty, OR = 5.9 for pulse pressure >66 mm Hg
 Nishijima et al46Severity of coronary disease*
 Chemla et al47Relation to concentric left ventricular hypertrophy
 Philippe F et al48Extent of coronary disease*
 Nakayama et al49Restenosis after coronary angioplasty
Augmentation index
 Hayashi et al50Severity of coronary disease, OR = 16.2
 Ueda et al51Restenosis after coronary angioplasty

OR = odds ratio.

A few cautionary notes are in order here. The transfer function process must be, and is, an approximation. The arterial tree is not exactly the same in all persons with all diseases at all ages and with all drug therapies, but it is basically similar. It is well known that atherosclerosis does not affect upper limb vessels in the same way as it affects central (carotid, cerebral, coronary) arteries and the aorta. Aging has little or no effect on stiffness of and wave velocity in the brachial artery and its radicles12,52–55; change in blood pressure also has little effect.56 As shown here (Fig. 6) and reported earlier,14,15 drug therapies do affect the transfer function but at frequencies at which harmonic components of the waveform are low. Given these basic similarities under different conditions, it is natural that one should try to exploit relative constancy of transfer functions in the upper limb. In so doing, one is at least advancing on previous views that central and peripheral systolic and pulse pressure were identical and that amplitude of transfer function remains at 1.0 at all frequencies. However, one must recognize the fact that the transfer function is not exactly constant under all conditions.

Use of the transfer function technique for generating the central pressure waveform has created the same controversy as did the same process for describing pressure/flow relationships as impedance in the 1950s. Although the latter approach is now generally accepted, it must be emphasized that both need be qualified with the words used by Taylor, McDonald, and Womersley … “to a first approximation.”6

Surprisingly, much of the criticism of the transfer function process relates to inaccuracies of the sphygmomanometer cuff in measurement of systolic (peak) and diastolic (nadir) pressure in the upper limb. This is an irrelevant and entirely separate issue. A transfer function process relates to waveforms. It cannot correct for errors of other methods used for calibration. Such errors affect all interpretations that follow from use of the conventional cuff sphygmomanometer.1,57

In conclusion, determination of central pressure is a new concept, and while theoretically attractive, has little clinical backing to support its usefulness. What data exist indicate that it is superior to conventional measures of upper limb pressure41–51,58 and that use of the cuff sphygmomanometer can be complemented by determination of the pressure pulse waveform in the upper limb.

References

1.

Smulyan
H
,
Siddiqui
DS
,
Carlson
RJ
,
London
GM
,
Safar
ME
:
Clinical utility of aortic pulses and pressures calculated from applanated radial-artery pulses
.
Hypertension
2003
;
42
:
150
155
.

2.

Hope
SA
,
Tay
DB
,
Meredith
IT
,
Cameron
JD
:
Use of arterial transfer functions for the derivation of aortic waveform characteristics
.
J Hypertens
2003
;
21
:
1299
1305
.

3.

O’Rourke
MF
,
Nichols
WW
:
Use of arterial transfer function for the derivation of aortic waveform characteristics (letter)
.
J Hypertens
2003
;
21
:
2195
2199
.

4.

Cloud
GC
,
Rajkumar
C
,
Kooner
J
,
Cooke
J
,
Bulpitt
CJ
:
Estimation of central aortic pressure by SphygmoCor requires intra-arterial peripheral pressures
.
Clin Sci
2003
;
105
:
219
225
.

5.

Womersley
JR
:
The mathematical analysis of the arterial circulation in a state of oscillatory motion
.
Technical Report Wade-TR. 56–614
.
Wright Air Development Center
.
Dayton, OH
,
1957
.

6.

McDonald
DA
,
Taylor
MG
:
The hydrodynamics of the arterial circulation
.
Prog Biophys Chem
1959
;
9
:
107
173
.

7.

McDonald
DA
:
Blood Flow in Arteries
.
Edward Arnold
,
London
,
1960
.

8.

Hamilton
WF
:
Measurement of the cardiac output
,in
Handbook of Physiology; Section 2, Circulation, Volume 1
.
American Physiological Society
,
Washington, DC
.
1962
, pp
551
584
.

9.

Remington
JW
:
The physiology of the aorta and major arteries
. In:
Handbook of Physiology; Section 2, Circulation
,
Volume 2
.
American Physiological Society
,
Washington DC
,
1962
, pp
799
838
.

10.

Milnor
WR
:
Hemodynamics
, 2nd ed.
Williams & Wilkins
,
Baltimore
,
1989
.

11.

O’Rourke
MF
,
Taylor
MG
:
Input impedance of the systemic circulation
.
Circ Res
1967
;
20
:
365
380
.

12.

Nichols
WW
,
O’Rourke
MF
:
McDonald’s Blood Flow in Arteries
, 4th ed.
Edward Arnold
,
London
,
1998
.

13.

O’Rourke
MF
,
Safar
M
,
Dzau
V
(eds):
Arterial Vasodilation
.
Edward Arnold
,
London
,
1993
, pp
117
133
,
220
223
.

14.

Karamanoglu
M
,
O’Rourke
MF
,
Avolio
AP
,
Kelly
RP
:
An analysis of the relationship between central aortic and peripheral upper limb pressure waves in man
.
Eur Heart J
1993
;
14
:
160
167
.

15.

Karamanoglu
M
,
Gallagher
DE
,
Avolio
AP
,
O’Rourke
MF
:
Pressure wave propagation in a multi-branched model of the human upper limb
.
Am J Physiol
1995
;
269
:
H1363
H1369
.

16.

Chen
C-H
,
Nevo
E
,
Fetics
B
,
Pak
PH
,
Yin
FCP
,
Maughan
WL
,
Kass
DA
:
Estimation of central aortic pressure waveform by mathematical transformation of radial tonometry pressure: validation of generalised transfer function
.
Circulation
1997
;
95
:
1827
1836
.

17.

Fetics
B
,
Nevo
E
,
Chen
CH
,
Kass
DA
:
Parametric model derivation of transfer function for non-invasive estimation of aortic pressure by radial tonometry
.
IEEE Trans Biomed Eng
1999
;
46
:
698
706
.

18.

Kass
DA
,
Chen
CH
,
Nevo
E
,
Fetics
B
,
Pak
PH
,
Maughan
WL
:
Estimation of central aortic pressure waveform by mathematical transformation of radial tonometry pressure data (response)
.
Circulation
1998
;
98
:
186
187
.

19.

Pauca
AL
,
O’Rourke
MF
,
Kon
ND
:
Prospective evaluation of a method for estimating ascending aortic pressure from the radial artery pressure waveform
.
Hypertension
2001
;
38
:
932
937
.

20.

Soderstrom
S
,
Nyberg
G
,
O’Rourke
MF
,
Sellgren
J
,
Ponten
J
:
Can a clinically useful aortic pressure wave be derived from a radial pressure wave?
.
Br J Anaesth
2002
;
88
:
481
488
.

21.

O’Rourke
M
,
Pauca
A
,
Kon
N
:
Generation of ascending aortic from radial artery pressure waveform (abstract)
.
J Am Coll Cardiol
2002
;
39
:
177B
.

22.

Gallagher
D
:
Analysis of pressure wave propagation in the human upper limb: physical determinants and clinical applications
. MD thesis.
University of New South Wales
,
Sydney
,
1993
.

23.

O’Rourke
MF
,
Gallagher
DE
:
Pulse wave analysis
.
J Hypertens
1996
;
14
(
suppl 5
):
S147
S157
.

24.

Gallagher
DE
,
Karamanoglu
M
,
Huang
G-H
,
Avolio
AP
,
O’Rourke
MF
:
Assessment of interobserver variation on peripheral pressure waveform analysis using a semi-automated system (abstract)
.
Aust New Zealand J Med
1991
;
21
:
527
.

25.

Gallagher
DE
,
Karamanoglu
M
,
Herok
G
,
Avolio
AP
,
Baird
DD
,
O’Rourke
MF
:
Apparent alteration in upper limb pressure wave transmission with changing heart rate (abstract)
.
Circulation
1993
;
86
(
suppl 1
):
459
.

26.

Kelly
RP
,
Hayward
CS
,
Ganis
J
,
Daley
JE
,
Avolio
AP
,
O’Rourke
MF
:
Non-invasive registration of the arterial pressure pulse waveform using high-fidelity applanation tonometry
.
J Vasc Med Biol
1989
;
1
:
142
149
.

27.

Kelly
R
,
Hayward
C
,
Avolio
A
,
O’Rourke
M
:
Noninvasive determination of age-related changes in the human arterial pressure
.
Circulation
1989
;
80
:
1652
1659
.

28.

Kelly
R
,
Fitchett
D
:
Noninvasive determination of aortic input impedance and external left ventricular power output: a validation and repeatability study of a new technique
.
J Am Coll Cardiol
1992
;
20
:
952
963
.

29.

Murgo
JP
,
Westerhof
N
,
Giolma
JP
,
Altobelli
SA
:
Aortic input impedance in normal man: relationship to pressure wave forms
.
Circulation
1980
;
61
:
105
116
.

30.

Taylor
MG
:
The input impedance of an assembly of randomly branching elastic tubes
.
Biophys J
1966
;
6
:
29
51
.

31.

Taylor
MG
:
Use of random excitation and spectral analysis in the study of frequency dependent parameters of the cardiovascular system
.
Circ Res
1966
;
18
:
585
595
.

32.

Murgo
JP
,
Millar
H
:
A new cardiac catheter for high fidelity differential pressure recordings
.
25th Annual Conference of Engineering in Medicine and Biology
,
1972
, p
303
.

33.

Kelly
RP
,
Karamanoglu
M
,
Gibbs
HH
,
Avolio
AP
,
O’Rourke
MF
:
Non-invasive carotid pressure wave registration as an indicator of ascending aortic pressure
.
J Vasc Med Biol
1989
;
1
:
241
247
.

34.

Chen
CH
,
Ting
CT
,
Nussbacher
A
,
Nevo
E
,
Kass
DA
,
Pak
P
,
Wang
SP
,
Chang
MS
,
Yin
FPC
:
Validation of carotid artery tonometry as a means of estimating augmentation index of ascending aortic pressure
.
Hypertension
1996
;
27
:
168
175
.

35.

Kroeker
EJ
,
Wood
EH
:
Comparison of simultaneously recorded central and peripheral arterial pressure pulses during rest, exercise and tilted position in man
.
Circ Res
1955
;
3
:
623
632
.

36.

Rowell
LB
,
Brengelmann
GL
,
Blackmon
JR
,
Bruce
RA
,
Murray
JA
:
Disparities between aortic and peripheral pulse pressures induced by upright exercise and vasomotor changes in man
.
Circulation
1968
;
37
:
954
964
.

37.

O’Rourke
MF
:
Influence of ventricular ejection on the relationship between central aortic and brachial pressure pulse in man
.
Cardiovasc Res
1970
;
4
:
291
300
.

38.

Lasance
HAJ
,
Wesseling
KH
,
Ascoop
CA
:
Peripheral pulse contour analysis in determining stroke volume
. Progress Report 5.
Institute of Medical Physics
,
Utrecht
,
1976
.

39.

O’Rourke
MF
,
Kelly
RP
,
Avolio
AP
,
Hayward
CS
:
Effects of arterial dilator agents on central aortic systolic pressure and on left ventricular hydraulic load
.
Am J Cardiol
1989
;
63
:
381
441
.

40.

Waddell
TK
,
Dart
AM
,
Medley
TL
,
Cameron
JD
,
Kingwell
BA
:
Carotid pressure is a better predictor of coronary artery disease than brachial pressure
.
Hypertension
2001
;
38
:
927
931
.

41.

Safar
ME
,
Blacher
J
,
Pannier
B
,
Guerin
AP
,
Marchais
SJ
,
Guyonvarc’h
PM
,
London
GM
:
Central pulse pressure and mortality in end-stage renal disease
.
Hypertension
2002
;
39
:
735
738
.

42.

Boutouyrie
P
,
Bussy
C
,
Lacolley
P
,
Girerd
X
,
Laloux
B
,
Laurent
S
:
Association between local pulse pressure, mean blood pressure, and large-artery remodelling
.
Circulation
1999
;
100
:
1387
1393
.

43.

Boutouyrie
P
,
Bussy
C
,
Hayoz
D
,
Hengstler
J
,
Dartois
N
,
Laloux
B
,
Brunner
H
,
Laurent
S
:
Local pulse pressure and regression of arterial wall hypertrophy during long-term antihypertensive treatment
.
Circulation
2000
;
101
:
2601
2606
.

44.

Boutouyrie
P
,
Tropeano
A
,
Asmar
R
,
Gautier
I
,
Benetos
A
,
Lacolley
P
,
Laurent
S
:
Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients
.
Hypertension
2002
;
39
:
10
15
.

45.

Lu
TM
,
Hsu
NW
,
Chen
YH
,
Lee
WS
,
Wu
CC
,
Ding
YA
,
Chang
MS
,
Lin
SJ
:
Pulsatility of ascending aorta and restenosis after coronary angioplasty in patients >60 years of age with stable angina pectoris
.
Am J Cardiol
2001
;
88
:
964
968
.

46.

Nishijima
T
,
Nakayama
Y
,
Tsumura
K
,
Yamashita
N
,
Yoshimaru
K
,
Ueda
H
,
Hayashi
T
,
Yoshikawa
J
:
Pulsatility of ascending aortic blood pressure waveform is associated with an increased risk of coronary heart disease
.
Am J Hypertens
2001
;
14
:
469
473
.

47.

Chemla
D
,
Antony
I
,
Hebert
JL
,
Lecarpentier
Y
,
Nitenberg
A
:
Increased aortic pulse pressure associated with concentric left ventricular hypertrophy in arterial hypertension (Abstract)
.
Am J Hypertens
2002
;
15
:
164A
.

48.

Philippe
F
,
Chemaly
E
,
Blacher
J
,
Mourad
JJ
,
Dibie
A
,
Larrazet
F
,
Laborde
F
,
Safar
ME
:
Aortic pulse pressure and extent of coronary artery disease in percutaneous transluminal coronary angioplasty candidates
.
Am J Hypertens
2002
;
15
:
672
677
.

49.

Nakayama
Y
,
Tsumura
K
,
Yamashita
N
,
Yoshimaru
K
,
Hayashi
T
:
Pulsatility of ascending aortic pressure waveform is a powerful predictor of restenosis after percutaneous transluminal coronary angioplasty
.
Circulation
2000
;
101
:
470
472
.

50.

Hayashi
T
,
Nakayama
Y
,
Tsumura
K
,
Yoshimaru
K
,
Ueda
H
:
Reflection in the arterial system and the risk of coronary heart disease
.
Am J Hypertens
2002
;
15
:
405
409
.

51.

Ueda
H
,
Nakayama
Y
,
Tsumura
K
,
Yoshimaru
K
,
Hayashi
T
,
Yoshikawa
J
:
Inflection point of ascending aortic waveform is a powerful predictor of restenosis after percutaneous transluminal coronary angioplasty
.
Am J Hypertens
2002
;
15
:
823
826
.

52.

Avolio
AP
,
Chen
SG
,
Wang
RP
,
Zhang
CL
,
Li
MF
,
O’Rourke
MF
:
Effects of aging on changing arterial compliance and left ventricular load in a northern Chinese urban community
.
Circulation
1983
;
68
:
50
58
.

53.

Lakatta
EG
,
Levy
D
:
Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: part II: the aging heart in health: links to heart disease
.
Circulation
2003
;
107
:
346
354
.

54.

Lakatta
EG
,
Levy
D
:
Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: part I: aging arteries: a “set up” for vascular disease
.
Circulation
2003
;
107
:
139
146
.

55.

Mitchell
GF
,
Benjamin
EJ
,
Kupka
MJ
,
Larson
MG
,
Levy
D
:
Differential changes in central and peripheral conduit vessel stiffness with advancing age in a community-based cohort: the NHLBI Framingham Heart Study (abstract)
.
J Am Coll Cardiol
2002
;
39
(
suppl A
):
139A
.

56.

Hayoz
D
,
Rutschmann
B
,
Perret
F
,
Niederberger
M
,
Tardy
Y
,
Mooser
V
,
Nussberger
J
,
Waeber
B
,
Brunner
HR
:
Conduit artery compliance and distensibility are not necessarily reduced in hypertension
.
Hypertension
1992
;
20
:
1
6
.

57.

Lane
D
,
Beevers
M
,
Barnes
N
,
Bourne
J
,
John
A
,
Malins
S
,
Beevers
DG
:
Inter-arm differences in blood pressure: when are they clinically significant?
.
J Hypertens
2002
;
20
:
1089
1095
.

58.

Weber
T
,
Auer
J
,
O’Rourke
MF
,
Kvas
E
,
Lassnig
E
,
Berent
R
,
Eber
B
:
Arterial stiffness, wave reflections and risk of coronary artery disease
.
Circulation
2004
;
109
:
184
189
.